Which of the following statement about rituximab is FALSE:
Correct Answer: It has dose-dependent kinetics
Description: Ans. (B) It has dose-dependent kinetics(Ref Goodman Gilman 12th/1746-1747, KDT 8th/e p931-932)Rituximab is a chimeric monoclonal antibody against CD-20 B-cell antigen. It acts by depleting B-cells.Rituximab follows first order kinetics. Its clearance remains constant irrespective of plasma concentration. Dose-dependent kinetics means zero-order kinetics i.e. clearance and t1/2 change with dose (plasma concentration). Drugs following zero-order kinetics are warfarin, alcohol, high dose aspirin, tolbutamide, theophylline and phenytoin.Infusion-related reactions are seen in approximately 50% of patients receiving first infusion. The incidence decreases with subsequent infusions. Starting with low doses and pre-treatment with steroids or antihistaminics are the methods to reduce infusion-related reactions.Rituximab may cause reactivation of hepatitis B. Patients should be screened for hepatitis B before initiation of therapy. It rarely causes reactivation of JC virus leading to progressive multifocal leukoencephalopathy.Rituximab can be used for treatment ofNon Hodgkin lymphomaMantle cell lymphomaChronic lymphocytic leukemiaAuto-immune hemolytic anemiaDiffuse large B cell lymphomaThrombotic thrombocytopenic purpura (TTP)Gastric lymphomaRheumatoid arthritisImmune thrombocytopenic purpura (ITP)Pemphigus vulgarisSjogren syndromeSLE
Category:
Pharmacology
Get More
Subject Mock Tests
Practice with over 200,000 questions from various medical subjects and improve your knowledge.
Attempt a mock test nowMock Exam
Take an exam with 100 random questions selected from all subjects to test your knowledge.
Coming SoonGet More
Subject Mock Tests
Try practicing mock tests with over 200,000 questions from various medical subjects.
Attempt a mock test now